Listed on
(Coverage)
JCR2011-2023
SJR2013-2020;2022-2023
CiteScore2012-2023
SCIE2012-2024
SCOPUS2017-2024
MEDLINE2016-2024
DOAJ2017;2019-2024
EMBASE2016-2024
OA Info.
| OA |
oa mark
based on the information
- 2017;2019;2020;2021;2022;2023;2024;2025;
|
| Keywords |
in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine |
| Review Process |
Peer review |
Journal info.
pages |
|
| Licences |
CC BY |
| Copyrights |
No |
| DOAJ Coverage |
Added on Date : 2018-05-02T14:55:40Z |
| Subject(s) |
Medicine |
Country
AUSTRALIA
Aime & Scopes
The aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine community and allied professions involved in the efforts of integrating molecular imaging and molecular therapy. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, point-of-care and personalized medicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed.
